Simon Ostergaard
Chief Executive Officer en CELLAVISION AB .
Fortuna: 111 760 $ al 31/03/2024
Perfil
Dr. Simon Ostergaard is a President & Chief Executive Officer at CellaVision AB and a Vice President & GM-Global Pathology Business at Agilent Technologies Sweden AB.
He received his MBA from Macquarie Graduate School of Management Pty Ltd..
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELLAVISION AB
0.02% | 31/12/2022 | 5 000 ( 0.02% ) | 111 760 $ | 31/03/2024 |
Cargos activos de Simon Ostergaard
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLAVISION AB | Chief Executive Officer | 21/03/2021 |
| Agilent Technologies Sweden AB | Corporate Officer/Principal | - |
Formación de Simon Ostergaard.
| Macquarie Graduate School of Management Pty Ltd. | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CELLAVISION AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Agilent Technologies Sweden AB |
- Bolsa de valores
- Insiders
- Simon Ostergaard
